02_06 HER-2 Low Breast Cancer and Sacutuzumab Govetecan

Talking About Tumors with Ryann and Ryan - A medical oncology podcast

Talking About Tumors द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Talking About Tumors या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

1+ y ago 22:30

MP3•एपिसोड होम

1. HER-2 Testing Algorithm
2. Trastuzumab Deruxtecan in HER-2 Low MBC
3. 2:1 Randomization, Treatment of Provider Choice
4. Sacutuzumab Govetacan for later line TNBC and HR positive MBC

Citations

As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.

DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.

Uptodate.com Waltham, MA: Wolters Kluwer.

Some highlighted references recommended to read related to this specific episode:

1.Wolff A et al. JCO. 2018;36(20):2105-2122. doi:10.1200/JCO.2018.77.8738

2.Modi S et al. NEJM. 2022;387(1):9-20. doi:10.1056/NEJMOA2203690/

3.BardiaI A et al. NEJM. 2021;384:1529-1541. doi:10.1056/NEJMOA2028485

4.Rugo H et al. JCO. Published online Aug 26, 2022 . doi:10.1200/JCO.22.01002

5.Rugo H et al. Ann Oncol. 2022;33(suppl_7):S808-S869. doi:10.1016/annonc/annonc1089

Disclosures

Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.